Largent EA, et al. - Although some states have legalized physician-assisted death (PAD) for patients who are competent yet terminally ill, those with dementia are excluded from PAD. Because discussion of the ethics and policies of expanding access to PAD to people with Alzheimer disease (AD) is growing, experts evaluated the attitudes of cognitively normal individuals toward PAD in a clinical trial. Participants were required to learn whether they had elevated amyloid-β, which is a biomarker that increases the risk for cognitive decline due to AD.